Analysis Immage Biotherapeutics Corp. (IMMG)
5/31/2024
Analysis of Immage Biotherapeutics Corp. (IMMG)
Immage Biotherapeutics Corp. (IMMG) data shows that there is missing information for various technical indicators such as RSI, MACD, and moving averages (SMA, EMA, WMA). This indicates that the data may be incomplete or the stock may not have enough trading history to generate these indicators.Without this information, it is challenging to provide a comprehensive analysis of Immage Biotherapeutics Corp. It is important to have complete and up-to-date data to make informed investment decisions.
I recommend gathering more recent and complete data on IMMG to conduct a thorough analysis of the stock's performance and potential investment opportunities.
Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits information for a specific company.In terms of financials, the company has strong operating cash flow and levered free cash flow, with a positive current ratio and a high total debt to equity ratio. The profit margin and operating margin are also healthy, indicating efficient operations. The company's fiscal year ends in September 2023, and it has shown a positive return on assets and return on equity.
Looking at stock statistics, the company has a low short ratio and a significant percentage of shares held by institutions. The stock price summary shows volatility in the stock's performance over the past year.
Valuation metrics reveal a high PEG ratio and forward PE ratio, with the company being relatively expensive based on price to book and price to sales ratios. The company's market capitalization and enterprise value are substantial.
Lastly, dividends and splits information shows a consistent dividend payout, with a recent dividend date and ex-dividend date. The company has also undergone a stock split in the past.
Income statement 💸
Here are the revenue figures for the company over the past four fiscal years:1. Fiscal Year 2023: Sales of $383,285,000,000
2. Fiscal Year 2022: Sales of $394,328,000,000
3. Fiscal Year 2021: Sales of $365,817,000,000
4. Fiscal Year 2020: Sales of $274,515,000,000
From these figures, we can observe the following trends:
- There was a decrease in sales from 2022 to 2023.
- Sales have generally been increasing over the past four years, with a significant jump from 2020 to 2021.
- The company experienced its highest sales figure in 2022.
These trends can provide insights into the company's performance and growth over the specified period.
Balance Sheet
These are balance sheets. Here are the conclusions:1. The total assets have been increasing over the years, reaching $365,725,000,000 in 2018.
2. Current assets fluctuate, with the highest value in 2019 at $162,819,000,000.
3. Non-current assets have been increasing steadily, with the highest value in 2019 at $175,697,000,000.
4. Total liabilities have also been increasing, reaching $255,355,000,000 in 2018.
5. Shareholders' equity has been fluctuating, with the highest value in 2018 at $107,147,000,000.
6. The company has been relying more on non-current assets to support its operations over the years.
7. There is a need to closely monitor and manage current liabilities to ensure financial stability.
Earnings
The company's results for the most recent quarter, ending on April 30, 2025, have not been provided at this time. The previous quarter's results, ending on February 27, 2025, were handled by the Transfer Agent. The quarter before that, ending on January 31, 2025, had results released After Hours. The results for the quarter ending on October 31, 2024, were not provided at the time. However, for the quarter ending on August 1, 2024, the company had an EPS estimate of 1.32.Cash Flow 💶
This is a cash flow statement. Here are some conclusions we can draw from the data:1. The company's free cash flow has been fluctuating over the years, with the highest value in 2022 and the lowest in 2020.
2. Operating cash flow has been relatively stable over the years, indicating consistent operational performance.
3. The company has been paying a significant amount in income taxes each year, with the highest amount in 2021.
4. The end cash position has also varied, reaching its peak in 2020 and its lowest point in 2022.
5. Financing activities have had a significant impact on the cash flow, with large amounts being used for common stock repurchase and debt issuance.
6. Investing activities show a mix of acquisitions, investments, and capital expenditures, with varying levels of cash flow impact each year.
7. Overall, the company's cash flow statement reflects a dynamic financial situation with fluctuations in different activities impacting the cash position.
Earnings estimate
Based on the analysts' estimates for future quarterly and annual earnings per share:1. For the current quarter ending on June 30, 2024, the average estimated EPS is $1.33, compared to $1.26 a year ago. The range of estimates is between $1.27 and $1.36, with 26 analysts providing forecasts.
2. For the next quarter ending on September 30, 2024, the average estimated EPS is $1.53, lower than the $1.46 reported a year ago. The EPS estimates range from $1.44 to $1.63, with 25 analysts contributing to the estimates.
3. For the current fiscal year ending on September 30, 2024, the average estimated EPS is $6.59, up from $6.13 in the previous year. The EPS estimates range from $6.43 to $6.92, with 39 analysts providing forecasts.
4. Looking ahead to the next fiscal year ending on September 30, 2025, the average estimated EPS is $7.23, compared to $6.59 in the previous year. The EPS estimates range from $6.40 to $7.90, with 39 analysts contributing to the estimates.
Overall, the analysts are generally forecasting an increase in earnings per share for both the current and next fiscal years, with some fluctuations in the quarterly estimates.
Revenue estimate
Based on the analysts' estimates for the future quarterly and annual sales of the company, the following conclusions can be drawn:1. For the current quarter ending on June 30, 2024, the average sales estimate is $83,776,900,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 24.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $92,375,300,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 24.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $386,681,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 37.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $411,555,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 37.
These estimates suggest a moderate growth trend in both quarterly and annual sales for the company, with a slightly higher growth rate expected in the next fiscal year compared to the current one.
Growth estimates
Based on the consensus estimates provided, we can draw the following conclusions regarding the growth rate of the company for different periods:1. Current Quarter: The estimated growth rate for the current quarter is 5.6%.
2. Next Quarter: The estimated growth rate for the next quarter is 4.8%.
3. Current Year: The estimated growth rate for the current year is 7.5%.
4. Next Year: The estimated growth rate for the next year is 9.7%.
5. Past 5 Years (per annum): The average growth rate for the past 5 years is 20.1% per annum.
6. Next 5 Years (per annum): The estimated growth rate for the next 5 years is 11% per annum.
These estimates suggest a positive growth trend for the company, with a slightly lower growth rate expected in the near term compared to the historical average. However, the company is still projected to experience solid growth over the next few years according to analyst consensus.
Price target
The analysts' forecast for the future price of the security is as follows:- Low: $164
- High: $250
- Median: $200
- Average: $202.26
- Current price: $191.57
- Currency: USD
Based on these forecasts, we can see that the analysts have a range of opinions on the future price of the security, with the low end at $164, the high end at $250, and the average at $202.26. The current price is below both the average and median forecast, indicating a potential upside according to the analysts' predictions.
This is not investment advice. Remember to verify the information provided here.
Get access to the full analysis
- Over 35 000 indexes
- CFD, Forex, Crypto and Stocks Exchange
- Over 150 Indicators
- Pattern and candle analysis
- Support and resistance levels
- Fundamental, technical and sentimental analysis
- Power from AI
